Body Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal Disease

被引:222
作者
Vivante, Asaf [1 ,2 ]
Golan, Eliezer [2 ,3 ]
Tzur, Dorit
Leiba, Adi [2 ]
Tirosh, Amir [7 ]
Skorecki, Karl [4 ,5 ]
Calderon-Margalit, Ronit [6 ]
机构
[1] Edmond & Lily Safra Childrens Hosp, Israeli Def Forces Med Corps, Chaim Sheba Med Ctr, Dept Pediat,Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Israel Renal Registry, Bristol, Avon, England
[4] Technion Israel Inst Technol, Rappaport Fac Med, Dept Nephrol, Haifa, Israel
[5] Technion Israel Inst Technol, Res Inst, Haifa, Israel
[6] Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth, Jerusalem, Israel
[7] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
关键词
OBESITY-RELATED GLOMERULOPATHY; US CHILDREN; KIDNEY-DISEASE; UNITED-STATES; FOLLOW-UP; PREVALENCE; OVERWEIGHT; POPULATION; PROTEINURIA; ASSOCIATION;
D O I
10.1001/2013.jamainternmed.85
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The relationship between adolescent body mass index (BMI) and future risk for end-stage renal disease (ESRD) is not fully understood, nor is it known the extent to which this association is limited to diabetic ESRD. We evaluated the association between BMI in adolescence and the risk for all-cause, diabetic, and nondiabetic ESRD. Methods: Medical data about 1 194 704 adolescents aged 17 years who had been examined for fitness for military service between January 1, 1967, and December 31, 1997, were linked to the Israeli ESRD registry in this nationwide population-based retrospective cohort study. Incident cases of treated ESRD between January 1, 1980, and May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) for treated ESRD among study participants for their BMI at age 17 years, defined in accord with the US Centers for Disease Control and Prevention BMI for age and sex classification. Results: During 30 478 675 follow-up person-years (mean [SD], 25.51 [8.77] person-years), 874 participants (713 male and 161 female) developed treated ESRD, for an overall incidence rate of 2.87 cases per 100 000 person-years. Compared with adolescents of normal weight, overweight adolescents (85th to 95th percentiles of BMI) and obese adolescents (>= 95th percentile of BMI) had an increased future risk for treated ESRD, with incidence rates of 6.08 and 13.40 cases per 100 000 person-years, respectively. In a multivariate model adjusted for sex, country of origin, systolic blood pressure, and period of enrollment in the study, overweight was associated with an HR of 3.00 (95% CI, 2.50-3.60) and obesity with an HR of 6.89 (95% CI, 5.52-8.59) for all-cause treated ESRD. Overweight (HR, 5.96; 95% CI, 4.41-8.06) and obesity (HR, 19.37; 95% CI, 14.13-26.55) were strong and independent risk factors for diabetic ESRD. Positive associations of overweight (HR, 2.17; 95% CI, 1.71-2.74) and obesity (HR, 3.41; 95% CI, 2.42-4.79) with nondiabetic ESRD were also documented. Conclusions: Overweight and obesity in adolescents were associated with significantly increased risk for all-cause treated ESRD during a 25-year period. Elevated BMI constitutes a substantial risk factor for diabetic and nondiabetic ESRD.
引用
收藏
页码:1644 / 1650
页数:7
相关论文
共 50 条
  • [21] Sleep traits and risk of end-stage renal disease: a mendelian randomization study
    Li, Kaixin
    Zhao, Jiaxi
    Yang, Wenjing
    Ye, Zhibin
    BMC MEDICAL GENOMICS, 2023, 16 (01)
  • [22] Cumulative hypertension burden and risk of end-stage renal disease
    Kim, Chang Seong
    Kim, Bongseong
    Choi, Hong Sang
    Bae, Eun Hui
    Ma, Seong Kwon
    Han, Kyung-Do
    Kim, Soo Wan
    HYPERTENSION RESEARCH, 2021, 44 (12) : 1652 - 1661
  • [23] Risk of Band Keratopathy in Patients with End-Stage Renal Disease
    Weng, Shih-Feng
    Jan, Ren-Long
    Chang, Chun
    Wang, Jhi-Joung
    Su, Shih-Bin
    Huang, Chien-Cheng
    Tseng, Sung-Huei
    Chang, Yuh-Shin
    SCIENTIFIC REPORTS, 2016, 6
  • [24] Sleep apnea in end-stage renal disease patients: risk factors and mortality
    Prabu, Pranav
    Acree, Lillian
    Waller, Jennifer L.
    Linder, Daniel F.
    Bollag, Wendy B.
    Mohammed, Azeem
    Padala, Sandeep
    Healy, William
    Kheda, Mufaddal
    Baer, Stephanie L.
    Dillard, Thomas
    Taskar, Varsha
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (05) : 465 - 470
  • [25] Epidemiology of end-stage renal disease
    Roderick, P
    CLINICAL MEDICINE, 2002, 2 (03) : 200 - 204
  • [26] Body Mass Index in 1.9 Million Adolescents and Stroke in Young Adulthood
    Bardugo, Aya
    Fishman, Boris
    Libruder, Carmit
    Tanne, David
    Ram, Amit
    Hershkovitz, Yael
    Zucker, Inbar
    Furer, Ariel
    Gilon, Roy
    Chodick, Gabriel
    Tiosano, Shmuel
    Derazne, Estela
    Tzur, Dorit
    Afek, Arnon
    Pinhas-Hamiel, Orit
    Bendor, Cole Daniel
    Yaniv, Gal
    Rotem, Ran Shmuel
    Twig, Gilad
    STROKE, 2021, 52 (06) : 2043 - 2052
  • [27] Exercise in End-Stage Renal Disease
    Segura-Orti, Eva
    Johansen, Kirsten L.
    SEMINARS IN DIALYSIS, 2010, 23 (04) : 422 - 430
  • [28] Anakinra for Refractory Pseudogout in Patients with End-stage Renal Disease on Haemodialysis
    Antoniadou, Christina
    Fytanidis, Nikolaos
    Devetzis, Vasileios
    Kantartzi, Konstantia
    Papagoras, Charalampos
    MEDITERRANEAN JOURNAL OF RHEUMATOLOGY, 2024, 35 (01):
  • [29] Cardiovascular disease in end-stage renal disease
    Park, Jung Tak
    Oh, Hyung Jung
    Kang, Shin-Wook
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2013, 56 (07): : 576 - 582
  • [30] Depression in End-Stage Renal Disease
    Fallon, Margaret
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2011, 49 (08) : 30 - 34